Adverse Event Profile of Tigecycline: Data Mining of the Public Version of the U.S. Food and Drug Administration Adverse Event Reporting System

Kaori Kadoyama; Toshiyuki Sakaeda; Akiko Tamon; Yasushi Okuno

doi:10.1248/bpb.35.967

Adverse Event Profile of Tigecycline: Data Mining of the Public Version of the U.S. Food and Drug Administration Adverse Event Reporting System

Biological and Pharmaceutical Bulletin ◽

10.1248/bpb.35.967 ◽

2012 ◽

Vol 35 (6) ◽

pp. 967-970 ◽

Cited By ~ 31

Author(s):

Kaori Kadoyama ◽

Toshiyuki Sakaeda ◽

Akiko Tamon ◽

Yasushi Okuno

Keyword(s):

Data Mining ◽

Adverse Event ◽

Drug Administration ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Adverse Event Profile ◽

Event Reporting ◽

The Public ◽

The U.S

Download Full-text

Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”

BioDrugs ◽

10.1007/s40259-021-00476-9 ◽

2021 ◽

Author(s):

Joerg Putzke ◽

Scott Haughie ◽

Kelly H. Zou ◽

Gopinath M. Ranganna

Keyword(s):

Adverse Event ◽

Supportive Care ◽

Drug Administration ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Disproportionality Analysis ◽

Event Reporting ◽

The U.S

Download Full-text

A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting system

Expert Opinion on Drug Safety ◽

10.1080/14740338.2022.2016696 ◽

2021 ◽

Author(s):

Qilin Zhang ◽

Yufeng Ding ◽

Bing Dai ◽

Yamin Shu

Keyword(s):

Data Mining ◽

Adverse Event ◽

Real World ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Public

Download Full-text

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System

International Journal of Medical Sciences ◽

10.7150/ijms.4397 ◽

2012 ◽

Vol 9 (5) ◽

pp. 322-326 ◽

Cited By ~ 22

Author(s):

Takao Tamura ◽

Toshiyuki Sakaeda ◽

Kaori Kadoyama ◽

Yasushi Okuno

Keyword(s):

Data Mining ◽

Adverse Event ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Public

Download Full-text

Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System

PLoS ONE ◽

10.1371/journal.pone.0028124 ◽

2011 ◽

Vol 6 (12) ◽

pp. e28124 ◽

Cited By ~ 38

Author(s):

Toshiyuki Sakaeda ◽

Kaori Kadoyama ◽

Yasushi Okuno

Keyword(s):

Data Mining ◽

Adverse Event ◽

Adverse Events ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Public ◽

Events Data

Download Full-text

Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations

International Journal of Medical Sciences ◽

10.7150/ijms.8.487 ◽

2011 ◽

Vol 8 (6) ◽

pp. 487-491 ◽

Cited By ~ 27

Author(s):

Toshiyuki Sakaeda ◽

Kaori Kadoyama ◽

Yasushi Okuno

Keyword(s):

Data Mining ◽

Adverse Event ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Public ◽

Clinical Observations ◽

Platinum Agents

Download Full-text

Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel

American Journal of Hematology ◽

10.1002/ajh.26246 ◽

2021 ◽

Author(s):

Graça M. Dores ◽

Christopher Jason ◽

Manette T. Niu ◽

Silvia Perez‐Vilar

Keyword(s):

Adverse Event ◽

Adverse Events ◽

Drug Administration ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The U.S

Download Full-text

Data Mining of the Public Version of the FDA Adverse Event Reporting System

International Journal of Medical Sciences ◽

10.7150/ijms.6048 ◽

2013 ◽

Vol 10 (7) ◽

pp. 796-803 ◽

Cited By ~ 161

Author(s):

Toshiyuki Sakaeda ◽

Akiko Tamon ◽

Kaori Kadoyama ◽

Yasushi Okuno

Keyword(s):

Data Mining ◽

Adverse Event ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Public

Download Full-text

Assessing fluoroquinolone‐associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system

International Journal of Clinical Practice ◽

10.1111/ijcp.13331 ◽

2019 ◽

Vol 73 (5) ◽

pp. e13331 ◽

Cited By ~ 7

Author(s):

Long Meng ◽

Jing Huang ◽

Yuntao Jia ◽

Huali Huang ◽

Feng Qiu ◽

...

Keyword(s):

Data Mining ◽

Adverse Event ◽

Aortic Aneurysm ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The Public ◽

Aortic Aneurysm And Dissection

Download Full-text

Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

Expert Opinion on Drug Safety ◽

10.1080/14740338.2017.1323867 ◽

2017 ◽

Vol 16 (7) ◽

pp. 761-767 ◽

Cited By ~ 27

Author(s):

Yasser M. Alatawi ◽

Richard A. Hansen

Keyword(s):

Adverse Event ◽

Drug Administration ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Empirical Estimation ◽

Event Reporting ◽

The U.S

Download Full-text

Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System

Diabetes Spectrum ◽

10.2337/diaspect.28.4.283 ◽

2015 ◽

Vol 28 (4) ◽

pp. 283-288 ◽

Cited By ~ 6

Author(s):

S. C. Jones ◽

D. L. Ryan ◽

V. S. W. Pratt ◽

A. Niak ◽

A. D. Brinker

Keyword(s):

Adverse Event ◽

Injection Site ◽

Drug Administration ◽

Extended Release ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The U.S

Download Full-text